BioSpace News Archive

Interim data from both clinical trials presented at the 2019 American College of Gastroenterology (ACG) Conference in San Antonio

PDS Biotechnology Corporation, a clinical-stage immuno-oncology company developing multiple therapies based on T-cell activating technology called Versamune® announced its financial results for the third quarter ended September 30, 2019.

DENTSPLY SIRONA Inc. announced its financial results for the three months ended September 30, 2019.

Dedicated to Developing and Commercializing Innovative Oncology Drugs and Therapies Propelling Future Growth

OsteoRemedies®, LLC, a company focused on providing simple solutions to complex disorders, is pleased to announce the full commercial launch of the REMEDY® Stemmed Knee Spacer at the 2019 American Association of Hip and Knee Surgeons in Dallas, TX.

Investment to support development of human-compatible xeno organs to address the global organ shortage crisis

Triple-S Management Corporation, a leading managed care company in Puerto Rico, announced its third quarter 2019 results.

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced that Brian J. Brille, Vice Chairman of the Company, will present at two upcoming investor healthcare conferences in New York City.

BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer indications, is pleased to announce it has been accepted for a poster presentation at the 61st Annual American Society of Hematology Meeting, which takes place from 7-10 December 2019 in Orlando, Florida.

Previously presented retrospective analysis showed that adult multiple sclerosis relapse patients taking Acthar Gel had a higher relapse resolution rate than those taking other late-line treatments